Raymond James Financial’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$864K Sell
136,696
-2,637
-2% -$17.8K ﹤0.01% 4107
2026
Q1
$908K Buy
139,333
+26,574
+24% +$165K ﹤0.01% 3927
2025
Q4
$645K Sell
112,759
-3,226
-3% -$19.9K ﹤0.01% 4088
2025
Q3
$791K Sell
115,985
-100
-0.1% -$757 ﹤0.01% 3836
2025
Q2
$1.04M Buy
116,085
+14,667
+14% +$86.9K ﹤0.01% 3557
2025
Q1
$546K Buy
101,418
+31,416
+45% +$214K ﹤0.01% 3886
2024
Q4
$522K Buy
+70,002
New +$576K ﹤0.01% 3884

Other funds holding ULBI

Raymond James Financial's ULBI Position: Q2 2026 in Review

Raymond James Financial reduced its Ultralife (ULBI) stake by 1.9% in Q2 2026, selling an estimated $17.8K and leaving 136,696 shares worth $864K. The position accounts for ﹤0.01% of the portfolio, ranked #4107.

Raymond James Financial first reported a position in ULBI in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.04M in Q2 2025. 52 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.

  • Raymond James Financial held 136,696 shares of Ultralife worth $864K as of Q2 2026.
  • Raymond James Financial sold 2,637 Ultralife shares in Q2 2026, an estimated $17.8K.
  • Ultralife made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4107 holding.
  • Raymond James Financial first reported a position in Ultralife in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Ultralife position peaked at $1.04M in Q2 2025.
  • 52 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.